Effect of High-risk Human Papillomavirus Viral Load on the Expression of Regulatory T Cells in Cervical Lesions
Department of Clinical Laboratory,First Affiliated Hospital of Henan Polytechnic University/Jiaozuo Second People's Hospital,Jiaozuo 454100,China
*Corresponding author:YU Yang,Associate chief technician;E-mail:cym20140808@126.com
YU Yang,FU Yanli,SUN Xiang. Effect of High-risk Human Papillomavirus Viral Load on the Expression of Regulatory T Cells in Cervical Lesions[J]. Chinese General Practice, 2019, 22(5): 538-543. DOI: 10.12114/j.issn.1007-9572.2018.00.394.
余杨,付艳丽,孙翔. 高危型人乳头瘤病毒载量对不同宫颈病变调节性T淋巴细胞表达的影响研究[J]. 中国全科医学, 2019, 22(5): 538-543. DOI: 10.12114/j.issn.1007-9572.2018.00.394.
[1]RICHARDSON L A,EL-ZEIN M,RAMANAKUMAR A V,et al.HPV DNA testing with cytology triage in cervical cancer screening:influence of revealing HPV infection status[J].Cancer Cytopathol,2015,123(12):745-754.DOI:10.1002/cncy.21596.
[2]BROBERG G,GYRD-HANSEN D,MIAO JONASSON J,et al.Increasing participation in cervical cancer screening:offering a HPV self-test to long-term non-attendees as part of RACOMIP,a Swedish randomized controlled trial[J].Int J Cancer,2014,134(9):2223-2230.DOI:10.1002/ijc.28545.
[3]HAGHSHENAS M,GOLINI-MOGHADDAM T,RAFIEI A,et al.Prevalence and type distribution of high-risk human papillomavirus in patients with cervical cancer:a population-based study[J].Infect Agent Cancer,2013,8(1):20.DOI:10.1186/1750-9378-8-20.
[4]BOSCOLO-RIZZO P,PAWLITA M,HOLZINGER D.From HPV-positive towards HPV-driven oropharyngeal squamous cell carcinomas[J].Cancer Treat Rev,2016,42(1):24-29.DOI:10.1016/j.ctrv.2015.10.009.
[5]JEMAL A,BRAY F,CENTER M M,et al.Global cancer statistics[J].CA Cancer J Clin,2011,61(2):69-90.DOI:10.3322/caac.20115.
[6]PIERSMA S J.Immunosuppressive tumor microenvironment in cervial cancer patients[J].Cancer Microenviron,2011,4(3):361-375.DOI:10.1007/s12307-011-0066-7.
[7]FREY A B.Suppression of T cell responses in the tumor microenvironment[J].Vaccine,2015,33(51):7393-7400.DOI:10.1016/j.vaccine.2015.08.096.
[8]KOSHIOL J,LINDSAY L,PIMENTA J M,et al.Persistent human papillomavirus infection and cervical neoplasia:a systematic review and meta-analysis[J].Am J Epidemiol,2008,168(2):123-137.DOI:10.1093/aje/kwn036.
[9]ROSITCH A F,KOSHIOL J,HUDGENS M G,et al.Patterns of persistent genital papillomavirus infection among women world-wide:a literature review and meta-analysis[J].Int J Cancer,2013,133(6):1271-1285.DOI:10.1002/ijc.27828.
[10]LI S,HU T,LV W,et al.Changes in prevalence and clinical characteristics of cervical cancer in the People's Republic of China:a study of 10,012 cases from a nationwide working group[J].Oncologist,2013,18(10):1101-1107.DOI:10.1634/theoncologist.
[11]BELLONE S,EL-SAHWI K,COCCO E,et al.Human papillomavirus type16(HPV-16) virus-like particle L1-specific CD8+ cytotoxic T lymphocytes(CTLs) are equally effective as E7-specific CD8+ CTLs in killing autologous HPV-16-positive tumor cells in cervical cancer patients:implications for L1 dendritic cell-based therapeutic vaccines[J].J Virol,2009,83(13):6779-6789.DOI:10.1128/JVI.02443-08.
[12]KLEMM F,JOYCE J A.Microenvironmental regulation of therapeutic response in cancer[J].Trends Cell Biol,2015,25(4):198-213.DOI:10.1016/j.tcb.2014.11.006.
[13]丁爱萍,张志新,张瑶,等.调节性T细胞在人乳头瘤病毒16整合状态的宫颈癌组织中的表达及意义[J].中国实用妇科与产科杂志,2014,30(5):374-378.
DING A P,ZHANG Z X,ZHANG Y,et al.The expression of Treg in HPV16 integrated cervical cancer[J].Chinese Journal of Practical Gynecology and Obstetrics,2014,30(5):374-378.
[14]HUBER V,CAMISASCHI C,BERZI A,et al.Cancer acidity:an ultimate frontier of tumor immune escape and a novel target of immunomodulation[J].Semin Cancer Biol,2017,43:74-89.DOI:10.1016/j.semcancer.2017.03.001.
[15]TANG H,QIAO J,FU Y X.Immunotherapy and tumor microenvironment[J].Cancer Lett,2016,370(1):85-90.DOI:10.1016/j.canlet.2015.10.009.
[16]VEIGA-PARGA T,SEHRAWAT S,ROUSE B T.Role of regulatory T cells during virus infection[J].Immunol Rev,2013,255(1):182-196.DOI:10.1111/imr.12085.
Chinese Society of Infectious Diseases and Parasitology,Chinese Society of Hepatology.The preventation and treatment of viralhepatitis[J].Chinese Journal of Infectious Diseases,2001,19(1):56-62.